| # | Drug | Count |
|---|---|---|
| 0 | ENTECAVIR | 5 |
| 1 | ADALIMUMAB | 3 |
| 2 | BICTEGRAVIR SODIUM, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE FUMARATE | 3 |
| 3 | CABOTEGRAVIR SODIUM | 3 |
| 4 | LAMIVUDINE | 3 |
| 5 | LAMIVUDINE ORAL | 3 |
| 6 | PREDNISOLONE | 3 |
| 7 | PREDNISOLONE ORAL | 3 |
| 8 | PREDNISOLONE ORAL SOLUTION | 3 |
| 9 | TACROLIMUS | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CABOTEGRAVIR SODIUM | 3 | 0.0019 |
| 1 | CIDOFOVIR ANHYDROUS | 1 | 0.0007 |
| 2 | IMIPENEM AND CILASTATIN SODIUM | 1 | 0.0005 |
| 3 | DEFEROXAMINE MESYLATE | 1 | 0.0005 |
| 4 | CYCLOSERINE | 1 | 0.0004 |
| 5 | ENTECAVIR | 5 | 0.0004 |
| 6 | ALFUZOSIN HCL | 1 | 0.0003 |
| 7 | RILPIVIRINE | 2 | 0.0003 |
| 8 | TENOFOVIR DISOPROXIL FUMARATE TABLETS | 2 | 0.0002 |
| 9 | EFAVIRENZ | 2 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 2 | 0.0001 |
| 1 | Antimycobacterial [EPC] | 2 | 0.0001 |
| 2 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 7 | 0.0001 |
| 3 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 3 | 0.0001 |
| 4 | Human Immunoglobulin G [EPC] | 1 | 0.0000 |
| 5 | Oxazolidinone Antibacterial [EPC] | 1 | 0.0000 |
| 6 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 3 | 0.0000 |
| 7 | Penem Antibacterial [EPC] | 1 | 0.0000 |
| 8 | Polyene Antifungal [EPC] | 1 | 0.0000 |
| 9 | Azole Antifungal [EPC] | 2 | 0.0000 |